BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10479693)

  • 1. Negative regulation of oligodendrocyte differentiation by galactosphingolipids.
    Bansal R; Winkler S; Bheddah S
    J Neurosci; 1999 Sep; 19(18):7913-24. PubMed ID: 10479693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfatide is a negative regulator of oligodendrocyte differentiation: development in sulfatide-null mice.
    Hirahara Y; Bansal R; Honke K; Ikenaka K; Wada Y
    Glia; 2004 Feb; 45(3):269-77. PubMed ID: 14730700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside.
    Bansal R; Stefansson K; Pfeiffer SE
    J Neurochem; 1992 Jun; 58(6):2221-9. PubMed ID: 1573402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids.
    Bansal R; Pfeiffer SE
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6181-5. PubMed ID: 2668957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of galactolipid elimination on oligodendrocyte development and myelination.
    Marcus J; Dupree JL; Popko B
    Glia; 2000 Jun; 30(4):319-28. PubMed ID: 10797612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient reversion of O4+ GalC- oligodendrocyte progenitor development in response to the phorbol ester TPA.
    Avossa D; Pfeiffer SE
    J Neurosci Res; 1993 Jan; 34(1):113-28. PubMed ID: 8423632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
    Coetzee T; Dupree JL; Popko B
    J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment.
    Gard AL; Pfeiffer SE
    Development; 1989 May; 106(1):119-32. PubMed ID: 2697546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.
    Bansal R; Warrington AE; Gard AL; Ranscht B; Pfeiffer SE
    J Neurosci Res; 1989 Dec; 24(4):548-57. PubMed ID: 2600978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactolipids in the formation and function of the myelin sheath.
    Dupree JL; Suzuki K; Popko B
    Microsc Res Tech; 1998 Jun; 41(5):431-40. PubMed ID: 9672425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead alters the developmental profile of the galactolipid metabolic enzymes in cultured oligodendrocyte lineage cells.
    Deng W; Poretz RD
    Neurotoxicology; 2001 Aug; 22(4):429-37. PubMed ID: 11577801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism.
    Pesheva P; Gloor S; Schachner M; Probstmeier R
    J Neurosci; 1997 Jun; 17(12):4642-51. PubMed ID: 9169525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.
    Dyer CA
    Mol Neurobiol; 1993; 7(1):1-22. PubMed ID: 8391270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance of oligodendrocytes and their progenitors by substratum topography.
    Webb A; Clark P; Skepper J; Compston A; Wood A
    J Cell Sci; 1995 Aug; 108 ( Pt 8)():2747-60. PubMed ID: 7593316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation.
    Oh LY; Denninger A; Colvin JS; Vyas A; Tole S; Ornitz DM; Bansal R
    J Neurosci; 2003 Feb; 23(3):883-94. PubMed ID: 12574417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of N-linked oligosaccharide processing glucosidases interfere with oligodendrocyte differentiation in culture.
    Bhat NR; Zhang P
    J Neurosci Res; 1994 Sep; 39(1):1-10. PubMed ID: 7528816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolipids and transmembrane signaling: antibodies to galactocerebroside cause an influx of calcium in oligodendrocytes.
    Dyer CA; Benjamins JA
    J Cell Biol; 1990 Aug; 111(2):625-33. PubMed ID: 2166054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfatide species with various fatty acid chains in oligodendrocytes at different developmental stages determined by imaging mass spectrometry.
    Hirahara Y; Wakabayashi T; Mori T; Koike T; Yao I; Tsuda M; Honke K; Gotoh H; Ono K; Yamada H
    J Neurochem; 2017 Feb; 140(3):435-450. PubMed ID: 27861899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.
    Vela JM; Molina-Holgado E; Arévalo-Martín A; Almazán G; Guaza C
    Mol Cell Neurosci; 2002 Jul; 20(3):489-502. PubMed ID: 12139924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of bipotential glial precursors into oligodendrocytes is promoted by interaction with type-1 astrocytes in cerebellar cultures.
    Aloisi F; Agresti C; D'Urso D; Levi G
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6167-71. PubMed ID: 3413085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.